US Patent Issued to NXERA PHARMA UK on Oct. 27 for "H4 antagonist compounds" (Canadian, British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,289, issued on Oct. 27, was assigned to NXERA PHARMA UK Ltd. (Great Britain).

"H4 antagonist compounds" was invented by Giles Albert Brown (Cambridge, Great Britain), Miles Stuart Congreve (Cambridge, Great Britain), Barry Teobald (Cambridge, Great Britain), Nigel Alan Swain (Cambridge, Great Britain), Charlotte Fieldhouse (Cambridge, Great Britain), Mark Pickworth (Cambridge, Great Britain), Malken Bayrakdarian (Quebec, Canada), Delphine Karila (Quebec, Canada) and Daniel Beaudoin (Quebec, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosures herein relate to novel compounds of formula (1):and salts thereof, wherein Y, Z, R1, R2, R3...